Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.

MG Kurilla, M Rowe, E Kieff - The Journal of experimental medicine, 1992 - rupress.org
Epstein-Barr virus (EBV), a human herpes virus with oncogenic potential, persists in B
lymphoid tissues and is controlled by virus-specific cytotoxic T lymphocyte (CTL) …

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

RJ Murray, MG Kurilla, JM Brooks… - The Journal of …, 1992 - pubmed.ncbi.nlm.nih.gov
Epstein-Barr virus (EBV), a human herpes virus with oncogenic potential, persists in B
lymphoid tissues and is controlled by virus-specific cytotoxic T lymphocyte (CTL) …

[引用][C] Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive …

RJ MURRAY, MG KURILLA… - The Journal of …, 1992 - pascal-francis.inist.fr
Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV)
: implications for the immune control of EBV-positive malignancies CNRS Inist Pascal-Francis …

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.

RJ Murray, MG Kurilla, JM Brooks - 1992 - cabidigitallibrary.org
Abstract Epstein-Barr virus (EBV), a human herpes virus with oncogenic potential, persists in
B lymphoid tissues and is controlled by virus-specific cytotoxic T lymphocyte (CTL) …

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.

RJ Murray, MG Kurilla, JM Brooks, WA Thomas… - The Journal of …, 1992 - cir.nii.ac.jp
抄録< jats: p> Epstein-Barr virus (EBV), a human herpes virus with oncogenic potential,
persists in B lymphoid tissues and is controlled by virus-specific cytotoxic T lymphocyte …

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.

RJ Murray, MG Kurilla, JM Brooks… - The Journal of …, 1992 - europepmc.org
Abstract Epstein-Barr virus (EBV), a human herpes virus with oncogenic potential, persists in
B lymphoid tissues and is controlled by virus-specific cytotoxic T lymphocyte (CTL) …

[PDF][PDF] Identification of Target Antigens for the Human Cytotoxic T Cell Response to Epstein-Barr Virus (EBV): Implications for the Immune Control of EBV-positive …

RJ Murray, MG Kuri, M Rowe, E Kieff, AB Rickinson - pdfs.semanticscholar.org
Summary Epstein-Barr virus (EBV), a human herpes virus with oncogenic potential, persists
in B lymphoid tissues and is controlled by virus-specific cytotoxic T lymphocyte (CTL) …

Identification of Target Antigens for the Human Cytotoxic T Cell Response to Epstein-Barr Virus (EBV): Implications for the Immune Control of EBV-positive …

RJ Murray, MG Kuri, M Rowe, E Kieff, AB Rickinson - ncbi.nlm.nih.gov
Abstract Epstein-Barr virus (EBV), a human herpes virus with oncogenic potential, persists in
B lymphoid tissues and is controlled by virus-specific cytotoxic T lymphocyte (CTL) …

[引用][C] Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive …

RJ MURRAY - J. Exp. Med., 1992 - cir.nii.ac.jp
Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV)
: implications for the immune control of EBV-positive malignancies | CiNii Research CiNii 国立 …

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.

RJ Murray, MG Kurilla, JM Brooks… - The Journal of …, 1992 - europepmc.org
Abstract Epstein-Barr virus (EBV), a human herpes virus with oncogenic potential, persists in
B lymphoid tissues and is controlled by virus-specific cytotoxic T lymphocyte (CTL) …